ReNeuron Group plc

Company Profile

Company website
Pharmaceuticals and Biotechnology (Biotechnology)
ReNeuron Group plc (AIM: RENE) is a global leader in cell-based therapeutics, harnessing its unique stem cell technologies to develop 'off the shelf' stem cell treatments, without the need for immunosuppressive drugs.

Investor Access

09 Sep
Event information

Management will hold the company’s AGM meeting at 09:30 on 9th September 2022 relating to the accounts for the year ended 31 March 2022

Covington and Burling LLP, Level 54, 22 Bishopsgate, London, EC2N 4BQ
Friday 9th September 2022 at 9:30am
Financial Calendar
 Event  Date
Year End 31 March
Half  Year End 30 September
Preliminary Results* July
Interim Results* December
AGM* September

* Months based on previous announcements of this kind